Understanding the mechanisms of cancers based on function sub-pathways

Pathway analysis has become a popular technology tool for gaining insight into the underlying biology of differentially expressed genes and proteins. Although many sub-pathways analysis methods have been proposed, the function of these sub-pathways is generally implicit. In this paper, we propose a function sub-pathway analysis (FSPA) method which includes all nodes reaching a specific function node at the downstream of pathways. The perturbation degree of a sub-pathway is defined as the negative of the log p-value of the sub-pathway. The proposed FSPA allows analyzing the differentially expressed genes in a sub-pathway with diseases in explicit function level. Results from six datasets of colorectal cancer, lung cancer and pancreatic cancer show that the proposed FSPA could identify more cancer associated pathways. And more importantly, it could identify which sub-pathways lead to a specific abnormal function, and to what extent it affects the function. Furthermore, the proposed perturbation degree could also analyze the imbalance of some functions involved in some biological process. The results by FSPA are helpful for elucidating the underlying mechanisms of cancers and designing therapeutic strategies.

[1]  Ralf Zimmer,et al.  Bioconductor’s EnrichmentBrowser: seamless navigation through combined results of set- & network-based enrichment analysis , 2016, BMC Bioinformatics.

[2]  E. Birney,et al.  Reactome: a knowledgebase of biological pathways , 2004, Nucleic Acids Research.

[3]  Gabriele Sales,et al.  graphite - a Bioconductor package to convert pathway topology to gene network , 2012, BMC Bioinformatics.

[4]  Liviu Badea,et al.  Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. , 2008, Hepato-gastroenterology.

[5]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[6]  Chunquan Li,et al.  The Implications of Relationships between Human Diseases and Metabolic Subpathways , 2011, PloS one.

[7]  Antonio Molino,et al.  Venous thromboembolism and lung cancer: a review , 2015, Multidisciplinary Respiratory Medicine.

[8]  Chunquan Li,et al.  SubpathwayMiner: a software package for flexible identification of pathways , 2009, Nucleic acids research.

[9]  Z. Szallasi,et al.  Evaluation of Microarray Preprocessing Algorithms Based on Concordance with RT-PCR in Clinical Samples , 2009, PloS one.

[10]  Joaquín Dopazo,et al.  Understanding disease mechanisms with models of signaling pathway activities , 2014, BMC Systems Biology.

[11]  S. Drăghici.  Statistical intelligence: effective analysis of high-density microarray data. , 2002, Drug discovery today.

[12]  Pooja Mittal,et al.  A novel signaling pathway impact analysis , 2009, Bioinform..

[13]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[14]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[15]  Rafael Rosell,et al.  Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer , 2011, International journal of cancer.

[16]  Purvesh Khatri,et al.  Ontological analysis of gene expression data: current tools, limitations, and open problems , 2005, Bioinform..

[17]  Yan Wang,et al.  Characterizing the Network of Drugs and Their Affected Metabolic Subpathways , 2012, PloS one.

[18]  K. Vermeulen,et al.  Cell cycle and apoptosis , 2003, Cell proliferation.

[19]  Krishna R. Kalari,et al.  FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. , 2009, Cancer cell.

[20]  W. V. van IJcken,et al.  Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction , 2010, PloS one.

[21]  Atul J. Butte,et al.  Ten Years of Pathway Analysis: Current Approaches and Outstanding Challenges , 2012, PLoS Comput. Biol..

[22]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Sandrine Dudoit,et al.  More power via graph-structured tests for differential expression of gene networks , 2012, 1206.6980.

[24]  Thomas Lengauer,et al.  Statistical Applications in Genetics and Molecular Biology Calculating the Statistical Significance of Changes in Pathway Activity From Gene Expression Data , 2011 .

[25]  P. Khatri,et al.  Global functional profiling of gene expression ? ? This work was funded in part by a Sun Microsystem , 2003 .

[26]  Monica Chiogna,et al.  Along signal paths: an empirical gene set approach exploiting pathway topology , 2012, Nucleic acids research.

[27]  Qi Zheng,et al.  GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis , 2008, Nucleic Acids Res..

[28]  Xuequn Shang,et al.  Subpathway Analysis based on Signaling-Pathway Impact Analysis of Signaling Pathway , 2015, PloS one.

[29]  P. Khatri,et al.  Profiling gene expression using onto-express. , 2002, Genomics.

[30]  K. Ho,et al.  A Susceptibility Gene Set for Early Onset Colorectal Cancer That Integrates Diverse Signaling Pathways: Implication for Tumorigenesis , 2007, Clinical Cancer Research.

[31]  Zsolt Tulassay,et al.  Inflammation, Adenoma and Cancer: Objective Classification of Colon Biopsy Specimens with Gene Expression Signature , 2008, Disease markers.

[32]  Finn Gyntelberg,et al.  Association between atherosclerosis and female lung cancer--a Danish cohort study. , 2003, Lung cancer.